Literature DB >> 17554151

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

Enqi Liu1, Masatoshi Morimoto, Shuji Kitajima, Tomonari Koike, Ying Yu, Hideo Shiiki, Michio Nagata, Teruo Watanabe, Jianglin Fan.   

Abstract

Vascular endothelial growth factor (VEGF) is an important mediator in maintaining normal kidney functions. In addition, several lines of evidence suggest that upregulation of VEGF in glomeruli may be associated with or cause renal dysfunction such as diabetic nephropathy. For elucidation of the pathologic consequences of high levels of VEGF in glomeruli, transgenic (Tg) rabbits that express human VEGF(165) isoform in both kidney and liver under the control of the human alpha-1-antitrypsin promoter were generated and characterized. With the use of heterozygous Tg rabbits and their littermates aged 8 to 55 wk, renal functions and structures were investigated. Compared with control rabbits, Tg rabbits exhibited progressive proteinuria with increased GFR at the early stage and decreased GFR at the later stage. Histologic examinations revealed that Tg rabbit kidneys were characterized by considerable glomerular hypertrophy as a result of increased proliferation of both glomerular capillaries and mesangial cells accompanied by prominent podocyte hypertrophy. With increasing age starting from 20 wk, Tg rabbit kidneys showed prominent formation of microaneurysms and capillary proliferation at the vascular pole area. At a later stage (55 wk), many glomeruli showed sclerosis and tuft collapse with the formation of glomerular cysts on a background of tubular atrophy and interstitial fibrosis. This study provides the first evidence that increased expression of VEGF in glomeruli directly causes the glomerular hypertrophy that is associated with proteinuria, suggesting that VEGF exerts multiple effects on the glomerular pathophysiologic processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554151     DOI: 10.1681/ASN.2006010075

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

1.  Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats.

Authors:  Jing Jin; Chao Peng; Su-zhen Wu; Hong-min Chen; Bai-fang Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

2.  High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.

Authors:  Min-Jung Park; Dong-Il Kim; Seul-Ki Lim; Joo-Hee Choi; Ho-Jae Han; Kyung-Chul Yoon; Soo-Hyun Park
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

3.  Nicotine increased VEGF and MMP2 levels in the rat eye and kidney.

Authors:  Mehmet Ates; Ferda Hosgorler; Oguz Yuksel; Sultan Kaya Unsal; Guven Guvendi; Asli Karakilic; Basar Koc; Sevim Kandis; Lutfiye Kanit; Nazan Uysal
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-02       Impact factor: 4.223

4.  Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis.

Authors:  Franziska Theilig; Anne Kathrin Enke; Brigitte Scolari; Danny Polzin; Sebastian Bachmann; Robert Koesters
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

Review 5.  Antifibrotic treatment and other new strategies for improving renal outcomes.

Authors:  Anna Mathew; Robyn Cunard; Kumar Sharma
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

6.  Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.

Authors:  Alaa S Awad; Ting Gao; Anzor Gvritishvili; Hanning You; Yanling Liu; Timothy K Cooper; W Brian Reeves; Joyce Tombran-Tink
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-24

Review 7.  Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.

Authors:  Jianglin Fan; Shuji Kitajima; Teruo Watanabe; Jie Xu; Jifeng Zhang; Enqi Liu; Y Eugene Chen
Journal:  Pharmacol Ther       Date:  2014-09-30       Impact factor: 12.310

Review 8.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

9.  Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.

Authors:  Samy Hakroush; Marcus J Moeller; Franziska Theilig; Brigitte Kaissling; Tjeerd P Sijmonsma; Manfred Jugold; Ann L Akeson; Milena Traykova-Brauch; Hiltraud Hosser; Brunhilde Hähnel; Hermann-Josef Gröne; Robert Koesters; Wilhelm Kriz
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy.

Authors:  Chun-Liang Lin; Feng-Sheng Wang; Yen-Chen Hsu; Cheng-Nan Chen; Min-Jen Tseng; Moin A Saleem; Pey-Jium Chang; Jeng-Yi Wang
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.